HUP0001048A2 - Új vegyületek - Google Patents

Új vegyületek

Info

Publication number
HUP0001048A2
HUP0001048A2 HU0001048A HUP0001048A HUP0001048A2 HU P0001048 A2 HUP0001048 A2 HU P0001048A2 HU 0001048 A HU0001048 A HU 0001048A HU P0001048 A HUP0001048 A HU P0001048A HU P0001048 A2 HUP0001048 A2 HU P0001048A2
Authority
HU
Hungary
Prior art keywords
novel compounds
clavulanic acid
new
subject
large amounts
Prior art date
Application number
HU0001048A
Other languages
English (en)
Inventor
Cecilia Anders
Barry Barton
John Patrick Griffin
Susan Jensen
Roy Henry Mosher
Ashish Sudhakar Paradkar
Original Assignee
Smithkline Beecham P.L.C.
The Governors Of The University Of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C., The Governors Of The University Of Alberta filed Critical Smithkline Beecham P.L.C.
Publication of HUP0001048A2 publication Critical patent/HUP0001048A2/hu
Publication of HUP0001048A3 publication Critical patent/HUP0001048A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Atalálmány új bakteriális génekre, valamint klavámők, példáűlklavűlánsav javítőtt előállítási eljárásaira vőnatkőzik. Atalálmánytárgyát képezik tővábbá a klavűlánsav főkőzőtt mennyiségű termeléséreképes új őrganizműsők is. ŕ
HU0001048A 1997-02-04 1998-02-02 Novel compounds HUP0001048A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product

Publications (2)

Publication Number Publication Date
HUP0001048A2 true HUP0001048A2 (hu) 2000-08-28
HUP0001048A3 HUP0001048A3 (en) 2001-09-28

Family

ID=10807030

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0001048A HUP0001048A3 (en) 1997-02-04 1998-02-02 Novel compounds

Country Status (32)

Country Link
US (5) US6936458B1 (hu)
EP (2) EP0970198B1 (hu)
JP (2) JP4227199B2 (hu)
KR (2) KR20050053794A (hu)
CN (2) CN1192107C (hu)
AP (1) AP1320A (hu)
AR (2) AR011100A1 (hu)
AT (1) ATE312926T1 (hu)
AU (1) AU735782B2 (hu)
BG (1) BG103704A (hu)
BR (1) BR9807144A (hu)
CA (1) CA2279207A1 (hu)
DE (1) DE69832783T2 (hu)
DZ (1) DZ2413A1 (hu)
EA (1) EA003773B1 (hu)
ES (1) ES2255149T3 (hu)
GB (1) GB9702218D0 (hu)
HU (1) HUP0001048A3 (hu)
ID (1) ID22144A (hu)
IL (1) IL131043A0 (hu)
MA (1) MA24464A1 (hu)
MY (1) MY140928A (hu)
NO (1) NO993758L (hu)
NZ (1) NZ336894A (hu)
OA (1) OA11082A (hu)
PL (1) PL334961A1 (hu)
SK (1) SK105499A3 (hu)
TR (1) TR199901862T2 (hu)
TW (2) TW589377B (hu)
UY (2) UY24874A1 (hu)
WO (1) WO1998033896A2 (hu)
ZA (1) ZA98868B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
WO2001030977A2 (en) * 1999-10-22 2001-05-03 Smithkline Beecham P.L.C. 5r clavam producing microorganisms with deleted lat and cvm genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
CN114072493A (zh) 2019-07-05 2022-02-18 葛兰素史密斯克莱知识产权（第2 号）有限公司 棒状链霉菌

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
IT1059403B (it) * 1975-02-07 1982-05-31 Glaxo Lab Ltd Procedimento per produrre acido clavulanico e suoi derivati nonche composizioni che lo contengono
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
CA2279207A1 (en) 1998-08-06
SK105499A3 (en) 2000-05-16
TW200307041A (en) 2003-12-01
PL334961A1 (en) 2000-03-27
KR20000070723A (ko) 2000-11-25
AP1320A (en) 2004-10-29
JP5042186B2 (ja) 2012-10-03
WO1998033896A3 (en) 1998-11-19
MA24464A1 (fr) 1998-10-01
MY140928A (en) 2010-02-12
DZ2413A1 (fr) 2003-01-04
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
JP2001511001A (ja) 2001-08-07
AU735782B2 (en) 2001-07-12
JP4227199B2 (ja) 2009-02-18
AU6295398A (en) 1998-08-25
ID22144A (id) 1999-09-09
CN1696301A (zh) 2005-11-16
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
US6936458B1 (en) 2005-08-30
AR018304A2 (es) 2001-11-14
HUP0001048A3 (en) 2001-09-28
AR011100A1 (es) 2000-08-02
EP0970198B1 (en) 2005-12-14
EA003773B1 (ru) 2003-08-28
EP1405913A3 (en) 2004-08-04
EA199900718A1 (ru) 2000-02-28
US20030166175A1 (en) 2003-09-04
DE69832783T2 (de) 2006-07-20
US20070298470A1 (en) 2007-12-27
TR199901862T2 (xx) 2000-12-21
US20030022321A1 (en) 2003-01-30
JP2009022298A (ja) 2009-02-05
ATE312926T1 (de) 2005-12-15
KR100514964B1 (ko) 2005-09-15
CN1251612A (zh) 2000-04-26
KR20050053794A (ko) 2005-06-08
BG103704A (en) 2000-05-31
TW589377B (en) 2004-06-01
EP0970198A2 (en) 2000-01-12
UY25197A1 (es) 1998-11-27
NZ336894A (en) 2001-08-31
BR9807144A (pt) 2000-01-25
NO993758L (no) 1999-08-03
AP9901614A0 (en) 1999-09-30
DE69832783D1 (de) 2006-01-19
US7344869B2 (en) 2008-03-18
CN1192107C (zh) 2005-03-09
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
EP1405913A2 (en) 2004-04-07
US20030124690A1 (en) 2003-07-03
IL131043A0 (en) 2001-01-28
ZA98868B (en) 1999-08-03

Similar Documents

Publication Publication Date Title
AU5485698A (en) Oxyiminopregnancarbolactone
DE69711632T2 (de) Methode zur dissoziation von biotin komplexen
DE69604560T2 (de) Die herstellung von fluorinierten organischen verbindungen
DK0938308T3 (da) Antiparasitiske midler
HUP0001048A2 (hu) Új vegyületek
ATE275153T1 (de) Antibiotika produzierende mikrobe
AU3109300A (en) Production of ascorbic acid using yeast
DE69402201D1 (de) Phosphorhaltiges, metallurgisches silizium zur herstellung von organohalosilanen
MY125674A (en) Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis
HUP9904510A2 (hu) Benzotiofének előállítására szolgáló eljárás
ID21520A (id) Proses untuk produksi fermentatif cephalosporin terdeasilasi
ATE244706T1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
DE69938427D1 (de) Tes gen und dessen verwendung
DE58907667D1 (de) Gen und Genprodukt zur Herstellung von beta-lactamverbindungen.
DE69903291D1 (en) Synthese von morphin-6-glucuronid
HK1049026A1 (zh) L-薄荷醇的製備方法
NO921097D0 (no) 4-substituerte azetidinoner, samt fremgangsmaate for fremstilling av dem
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
JPS5523994A (en) Novel microorganism
EP0969094A3 (en) Thermostable esterase and its gene
ATE215561T1 (de) Methylsulfomycin 1, verfahren zu dessen herstellung und verwendung
MX9708398A (es) Procedimiento para la obtencion de ariluracilos substituidos.
ECSP982392A (es) Nuevos compuestos
NO972960L (no) E.coli-mutant med redusert produksjon av organisk syre
IT1270834B (it) Disolfuro chinolico

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees